Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) [Phase 2]
Phase 2 trial evaluating pembrolizumab plus lenvatinib in previously treated patients with select solid tumors; results on efficacy and safe…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer [Phase 2]
Phase 2 trial comparing MV-NIS versus investigator's choice chemotherapy in patients with ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan
This completed study investigates the prevalence of HER2 IHC 3+ and characterizes clinicopathologic features of gynecologic cancers in Taiwa…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors [Phase 2]
Phase 2 study evaluating SOT101 in combination with pembrolizumab in selected advanced solid tumors was terminated; results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies [Phase 1]
This clinical trial update notes the termination of a Phase 1 study of BDC-3042 as a single agent and in combination with cemiplimab in pati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression [Phase 1, Phase 2]
Clinical trial update for BT5528-100 (Phase 1/2) in EphA2-expressing advanced solid tumors. The study includes urothelial carcinoma, ovarian…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors [Phase 1]
Phase 1 basket trial evaluating customized autologous TCR-T cell therapies across multiple locally advanced or metastatic solid tumors, spon…
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Trial Evaluating TG4050 in Ovarian Carcinoma. [Phase 1]
Phase 1 trial evaluating TG4050 for ovarian cancer (including fallopian tube and peritoneal cancers) has completed with results posted.
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies [Phase 1, Phase 2]
Clinical trial update for BT8009-100 in nectin-4 expressing advanced malignancies (Phase 1/2) with status ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer [NA]
Clinical trial investigating transvaginal ultrasonography as a screening method for ovarian cancer; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin. [Phase 2]
This Phase 2, double-blind non-inferiority trial compares cilastatin to sodium thiosulfate for nephroprotection during debulking surgery wit…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Multimedia Aid for Genetic Testing in Gynecologic Oncology [NA]
A clinical trial update about a multimedia aid to improve genetic testing uptake in gynecologic cancers. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]
Phase I/II trial of autologous T cells engineered to express T-cell receptors (TCRs) in patients with solid tumors was terminated with resul…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer [Phase 1]
This clinical trial update confirms that MEN2501 is being evaluated in a first-in-human Phase 1 study for platinum-resistant ovarian cancer,…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update reports termination of NUV-868 as monotherapy and in combination with olaparib or enzalutamide in adults with adva…
-
CLINICAL_TRIALS research · 2025-11-05Clinical Trial Update: Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin [Phase 2]
Phase 2 clinical trial evaluating belzutifan for recurrent clear cell carcinoma of gynecologic origin is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer [NA]
Pilot randomized controlled trial evaluating a collaborative agenda-setting intervention (CASI) for patients with ovarian cancer. The study …
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial update for BL-M17D1 in patients with HER2-expressing or HER2-mutant advanced or metastatic solid tumors; the study is…
-
CLINICAL_TRIALS research · 2025-11-04Clinical Trial Update: Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy [Phase 3]
Phase 3 randomized trial comparing two dosing schedules for hypofractionated image-guided radiation therapy in melanoma and ovarian cancer. …
-
CLINICAL_TRIALS research · 2025-11-03Clinical Trial Update: Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. [Phase 1, Phase 2]
A Phase 1a/1b clinical trial evaluating TILT-123 (oncolytic adenovirus) with pembrolizumab, and with pegylated liposomal doxorubicin, for pl…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [EARLY_Phase 1]
This clinical trial update reports the completion of an early-phase Phase 1 vaccine therapy trial for patients with Stage IIIC-IV ovarian ep…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Clinical Pre-screening Protocol for Ovarian Cancer
Allarity Therapeutics reports an ongoing clinical trial evaluating a pre-screening protocol for ovarian cancer; the study is currently recru…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Genetic Education in BRCA Families [NA]
A Georgetown University-sponsored clinical trial focused on genetic education in BRCA families is currently enrolling by invitation for part…
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: A Trial of Vigil for Participants With Ovarian Cancer [Phase 2]
Phase 2 trial update for Gradalis' Vigil in ovarian cancer, noting the study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating mirvetuximab soravtansine with carboplatin for FRα-expressing, platinum-sensitive epithelial ovarian cance…